Who
John D. Fraser
Director
Company insider
Files Form 4 as: Director, Aspira Women's Health.
In numbers
- Trades disclosed
- 7
- Buys
- 2
- Sells
- 0
- Bought
- $22K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 17 Sep 2025
- Last trade
- 2 Dec 2025
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Dec 2025filed 4 Dec 2025 | Aspira Women's Healthoption or derivative | SEC FORM 4 Code A | —314,811 at $0.00 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Health | SEC FORM 4 Bought | $7,37516,389 at $0.45 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Healthoption or derivative | SEC FORM 4 Code P | —12,292 at $0.00 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Healthoption or derivative | SEC FORM 4 Code P | —12,292 at $0.00 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Health | SEC FORM 4 Bought | $7,37516,389 at $0.45 | filing |
| 17 Sep 2025filed 19 Sep 2025 | Aspira Women's Healthoption or derivative | SEC FORM 4 Code P | —12,292 at $0.00 | filing |
| 17 Sep 2025filed 19 Sep 2025 | Aspira Women's Health | SEC FORM 4 Bought | $7,37516,389 at $0.45 | filing |
News
No headline names them, or the companies they trade most, lately.